Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001144204-17-046095
Filing Date
2017-08-31
Accepted
2017-08-31 12:10:05
Documents
71

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A v473778_s1a.htm S-1/A 1047825
2 EXHIBIT 23.1 v473778_ex23-1.htm EX-23.1 2798
3 GRAPHIC v473778_logo.jpg GRAPHIC 9291
  Complete submission text file 0001144204-17-046095.txt   7261401

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fencf-20170630.xml EX-101.INS 1968832
5 XBRL TAXONOMY EXTENSION SCHEMA fencf-20170630.xsd EX-101.SCH 69872
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20170630_cal.xml EX-101.CAL 29030
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20170630_def.xml EX-101.DEF 364347
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20170630_lab.xml EX-101.LAB 368227
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20170630_pre.xml EX-101.PRE 408466
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-219884 | Film No.: 171062733
SIC: 2836 Biological Products, (No Diagnostic Substances)